New York, NY (PRWEB) November 26, 2013
Medicis, A Division of Valeant Pharmaceuticals -- the aesthetic company behind the popular Restylane dermal filler, in partnership with ModiFace Inc., the leading developer in virtual makeover technology -- is announcing the launch of the Restylane Reveal treatment visualization application. The new iPad application enables anyone to simulate the effects of Restylane on their photo taken with the iPad or uploaded to the app. The effects can be customized as to the amount and areas of facial treatment, and for the first time in the U.S., can illustrate potential results of lip enhancement. Once the visualization is complete, the before and after images can be saved on the iPad, emailed to friends and family, and even shared to various social networking platforms. The iPad application also includes before and after photos showing actual results of Restylane treatment, as well as testimonial videos.
"The Restylane Reveal app is an ideal tool for physicians to start a discussion about aesthetic treatments, and an amazing app for patients to answer their what-if questions," said Dr. Parham Aarabi, Founder and CEO of ModiFace Inc.
"For individuals considering treatment, the Restylane Reveal iPad app is an easy and entertaining way to see potential results on their own photos. It will be an outstanding dialog-starter for patients and their treatment providers. The Restylane Reveal iPad app breaks new ground with the inclusion of actual patient before and after photos and testimonial videos," said Rob Catlin, Director of Marketing, Medicis, a Division of Valeant Pharmaceuticals.
For more information about the app, including downloading it, please visit: https://itunes.apple.com/app/id731592913
For indication and important safety information for the Restylane family of products, please see below or visit http://www.RestylaneUSA.com.
ModiFace is the leading virtual beauty company with unique anti-aging, skin-care, cosmetics, and hair simulation technology across all platforms (web, in-store kiosk, Facebook, iPhone, iPad, Android, and in-ad-unit). Based on more than a decade of advanced facial recognition research at Stanford University, ModiFace's patented technology currently powers virtual makeover applications for Medicis, L’Oreal, Make Up For Ever, Inglot Cosmetics, Obagi, Jane Iredale, Allergan, Vogue, Seventeen, Marie Claire, and BASF. ModiFace's set of mobile applications on iPhone/iPad/Android devices have been downloaded nearly 25M times and have resulted in half a billion virtual product try-ons.
Medicis is dedicated to helping patients attain a healthy and youthful appearance and self–image. The Company´s portfolio of aesthetic products includes the Restylane family: Restylane® Injectable Gel, Restylane-L® Injectable Gel with 0.3% Lidocaine, Perlane® Injectable Gel, and Perlane-L® Injectable Gel with 0.3% Lidocaine.
Indication for the Restylane family of products:
The Restylane family of products includes Restylane, Restylane-L, Perlane, and Perlane-L. These products can be used to add volume and fullness to the skin to correct moderate to severe facial wrinkles and folds, such as the lines from your nose to the corners of your mouth (nasolabial folds). Restylane and Restylane-L may also be used for lip enhancement in patients over 21 years. Ask your doctor which is right for you.
Important Safety Considerations for the Restylane family of products:
Products in the Restylane family should not be used by people with previous bad allergies, particularly to microorganisms known as gram-positive bacteria, or by people with serious allergies to drugs that have previously required in-hospital treatment. These products should not be used by people with bleeding disorders. Products should not be injected anywhere except the skin, just under the skin (Perlane and Perlane-L only), or in the lips (Restylane and Restylane-L only). Restylane-L and Perlane-L should not be used by anyone with a known allergy to lidocaine.
Use at the site of skin sores, pimples, rashes, hives, cysts, or infection should be postponed until healing is complete. In these instances, product use could delay healing or make your skin problems worse. After treatment, you might have some swelling, redness, pain, bruising, or tenderness. These are typically mild in severity and normally last less than 7 days in nasolabial folds and less than 14 days in lips. Swelling may be more likely in patients under 36 years, and bruising may be more likely in patients over 35 years. Rarely, the doctor may inject into a blood vessel, which can damage the skin. Although rare, red or swollen small bumps may occur. If you have had facial cold sores before, an injection can cause an outbreak. To avoid bruising and bleeding, you should not use the products if you have recently used drugs that thin your blood or prevent clotting. Products should not be used during pregnancy, when breastfeeding, or in patients under 18 years for nasolabial folds.
Treatment volume should be limited to 6.0 mL in wrinkles and folds, such as nasolabial folds, and limited to 1.5 mL per lip (Restylane and Restylane-L only), as greater amounts significantly increase moderate and severe injection site reactions. The safety or effectiveness of treatment in areas other than nasolabial folds and lips (Restylane and Restylane-L only) has not been established in controlled clinical studies.
The Restylane family of products is available only through a licensed practitioner. Complete product and safety information is available at http://www.RestylaneUSA.com.
*The Restylane Reveal app is intended for illustrative, demonstrative and entertainment purposes only. The results displayed in the application may not reflect actual results. Only a physician can determine whether Restylane is an appropriate treatment for a patient and how much correction the patient can actually expect.
Except as otherwise indicated, all product names, slogans and other marks are trademarks of the Valeant family of companies.